Roche

Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi
BioPharma Dive
Wed, 04/26/17 - 09:29 pm
earnings
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Sanofi
Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Fierce Pharma
Wed, 04/19/17 - 04:21 pm
earnings
drug pricing
Bristol-Myers Squibb
AbbVie
Roche
Roche's Tecentriq wins FDA OK as first-line treatment in bladder cancer
Fierce Pharma
Tue, 04/18/17 - 09:00 pm
Roche
Tecentriq
bladder cancer
FDA
Roche claims that its interim update on hemophilia A drug is positive. But it’s hard to gauge.
Endpoints
Mon, 04/17/17 - 11:07 am
Roche
hemophilia A
emicizumab
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Fierce Pharma
Fri, 04/14/17 - 10:03 am
drug discounts
drug pricing
Roche
Neurocrine
Sanofi
Regeneron
Tesaro
Novartis
Bristol-Myers to license two drugs to Biogen, Roche
Yahoo/Reuters
Thu, 04/13/17 - 11:52 am
Bristol-Myers Squibb
Biogen
Roche
BMS-986168
BMS-986089
4 Reasons Why Roche Will Have the Best Growth in Big Pharma... and 1 Reason Why It Won't
Motley Fool
Wed, 04/12/17 - 10:33 am
Roche
Tecentriq
Perjeta
HER-2 postive breast cancer
Ocrevus
MS
multiple sclerosis
diagnostics
generics
biosimilars
Roche unit Genentech takes on Pfizer with new lung cancer data
BioPharma Dive
Mon, 04/10/17 - 11:10 am
Roche
Genentech
Pfizer
Xalkori
Alecensa
non-small cell lung cancer
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
Why Roche's New Drug Is Bad News For Biogen
Barron's
Sun, 04/9/17 - 12:20 pm
Roche
Biogen
Ocrevus
multiple sclerosis
MS
Tysabri
Tecfidera
The cost of cancer: new drugs show success at a steep price
Yahoo/Reuters
Mon, 04/3/17 - 09:13 am
cancer
Bristol-Myers Squibb
Merck
Roche
Roche secures FDA approval for Ocrevus for two types of MS
BioPharma Dive
Tue, 03/28/17 - 11:56 pm
Roche
Ocrevus
FDA
ocrelizumab
MS
multiple sclerosis
Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
Yahoo/Reuters
Thu, 03/23/17 - 09:32 am
Sanofi
Roche
GSK
FDA
Ocrevus
MS
Dupixent
eczema
generics
Advair
Mylan Labs
Roche trims workforce in struggling U.S. diabetes market
BioPharma Dive
Thu, 03/16/17 - 10:32 pm
Roche
layoffs
diabetes
Roche and Mylan settle a scrap over Herceptin, clearing path to a global launch of a knockoff drug
Endpoints
Mon, 03/13/17 - 10:13 am
Roche
Mylan Labs
Herceptin
Perjeta
breast cancer
Roche is bringing back gantenerumab from the dead, taking another stab at Alzheimer’s PhIII
Endpoints
Tue, 03/7/17 - 10:29 am
Roche
gantenerumab
Alzheimer's disease
clinical trials
Roche and Novartis CEOs nab all-but-matching pay of 12M francs for 2016
Fierce Pharma
Fri, 03/3/17 - 09:18 am
Roche
Novartis
Pharma CEOs
executive pay
Severin Schwan
Joe Jimenez
Roche shares spike as PhIII breast cancer combo with Perjeta scores a success, Puma takes a beating
Endpoints
Thu, 03/2/17 - 10:41 am
Roche
breast cancer
clinical trials
Perjeta
Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's
Bloomberg
Thu, 03/2/17 - 10:16 am
Alzheimer's disease
drug development
Roche
Merck
Eli Lilly
Biogen
Roche to start new trial of AC Immune drug against Alzheimer's
Yahoo/Reuters
Tue, 02/28/17 - 10:05 am
Roche
AC Immune
Alzheimer's disease
clinical trials
crenezumab

Pages